North Augusta, SC, United States of America

Ruoping Zhang

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • North Augusta, PA (US) (2018)
  • North Augusta, SC (US) (2017 - 2023)

Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Ruoping Zhang

Introduction

Ruoping Zhang is a prominent inventor based in North Augusta, SC (US). He has made significant contributions to the field of biochemistry, particularly in the development of ultra-pure agonists of guanylate cyclase C. With a total of 8 patents to his name, Zhang's work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Zhang's latest patents focus on the purification processes of peptides that include a guanylate cyclase C (GCC) agonist sequence. The invention provides methods for purifying these peptides, which are selected from a specific group of sequences. The processes involve a solvent exchange step prior to a freeze-drying (lyophilization) step, ensuring the production of ultra-pure agonists.

Career Highlights

Throughout his career, Ruoping Zhang has worked with notable companies such as Bausch Health Ireland Limited and Synergy Pharmaceuticals, Inc. His expertise in peptide purification and biochemistry has been instrumental in advancing research and development in these organizations.

Collaborations

Zhang has collaborated with several professionals in his field, including Kunwar Shailubhai and Stephen Comiskey. These partnerships have contributed to the successful development of his innovative patents.

Conclusion

Ruoping Zhang's contributions to the field of biochemistry through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…